Agios Appoints Ian Clark to Board of Directors
Jan 03, 2017 13:03 pm UTC| Business
CAMBRIDGE, Mass., Jan. 03, 2017 -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the appointment of Ian Clark to its board...
Agios Appoints Ian Clark to Board of Directors
Jan 03, 2017 13:03 pm UTC| Business
CAMBRIDGE, Mass., Jan. 03, 2017 -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the appointment of Ian Clark to its board...
JLT Specialty USA Announces Appointment of Paul Cohen as Senior Vice President
Jan 03, 2017 13:03 pm UTC| Business
LOS ANGELES, Jan. 03, 2017 -- JLT Specialty USA, a U.S. subsidiary of Jardine Lloyd Thompson Group plc. (JLT), one of the world’s leading specialty-focused providers of insurance, reinsurance and employee benefits...
JLT Specialty USA Announces Appointment of Paul Cohen as Senior Vice President
Jan 03, 2017 13:03 pm UTC| Business
LOS ANGELES, Jan. 03, 2017 -- JLT Specialty USA, a U.S. subsidiary of Jardine Lloyd Thompson Group plc. (JLT), one of the world’s leading specialty-focused providers of insurance, reinsurance and employee benefits...
JLT Specialty USA Announces Appointment of Paul Cohen as Senior Vice President
Jan 03, 2017 13:03 pm UTC| Business
LOS ANGELES, Jan. 03, 2017 -- JLT Specialty USA, a U.S. subsidiary of Jardine Lloyd Thompson Group plc. (JLT), one of the world’s leading specialty-focused providers of insurance, reinsurance and employee benefits...
JLT Specialty USA Announces Appointment of Paul Cohen as Senior Vice President
Jan 03, 2017 13:03 pm UTC| Business
LOS ANGELES, Jan. 03, 2017 -- JLT Specialty USA, a U.S. subsidiary of Jardine Lloyd Thompson Group plc. (JLT), one of the world’s leading specialty-focused providers of insurance, reinsurance and employee benefits...
Jan 03, 2017 13:03 pm UTC| Business
NEW YORK, Jan. 03, 2017 -- Avenue Therapeutics, Inc. (“Avenue”), a Fortress Biotech (NASDAQ:FBIO) Company, today announced that Notices of Allowance have now been received from the U.S. Patent and Trademark Office...